中国科技期刊卓越行动计划推介:LabMedDiscovery|第2卷第1期

科创中国 2025-04-18 14:23:45

近日,由上海交通大学、上海交通大学医学院附属瑞金医院共同主办,上海交通大学医学院医学技术学院官方刊物LabMed Discovery第2卷第1期于2025年3月正式上线。汇聚了1篇LMD主编Khosrow Adeli的社论、2篇研究性研究(主题涉及深静脉血栓形成的遗传危险因素研究、抗结核治疗研究),5篇综述文章(主题涉及疟疾和新冠肺炎合并感染的研究、食管癌代谢组学和微生物组学的研究、登革热病毒研究、Akkermansia muciniphila细胞外囊泡研究等),1篇为围绕人工智能在学术出版中的作用,采访了Leukemia主编Robert Peter Gale教授,1篇快报,共计10篇文章。欢迎各位专家学者关注并下载。

01

Editorial

题目:The launch of LabMed Discovery: A key platform for advancing laboratory medicine

作者:Khosrow Adeli

02

Research Article

题目:Anticoagulant protein C p.Lys193del mutation and promoter region polymorphisms: Genetic risk factors of deep venous thrombosis

作者:Xu-qian Wei, Xiao-lei Yi, Wei-bin Chen, Jin Tang, Jing Dai

题目:Plasma dynamic metabolomics during anti-tuberculosis treatment identifies an amino acid panel with diagnostic potential

作者:Yong Li, Cheng-cheng Yao, Ping Ji, Hui-yu Wang, Shu-jun Wang, Ying Wang, Qi-jian Cheng, Lu Xia, Ying-ying Chen

03

Review

题目:Interplay of malaria and COVID-19: Implications for coinfection

作者:Anu Shibi Anilkumar, Ramakrishnan Veerabathiran

题目:Review of metabolomics and microbiomics in esophageal cancer: From pathogenesis to prognosis

作者:Yu-qin Cao, Yu-meng Cheng, Tian-cheng Li, Ya-jie Zhang, Cheng-qiang Li, He-cheng Li

题目:Rosmarinic acid and dengue virus: Computational insights into antiviral potential

作者:Sugumar Sujitha, Rengarajan Murugesan

题目:Insights into morphine: Extraction, structural characterization, and pharmacological properties

作者:Javeriya Ahrar, Md. Nematullah, Md. Azizur Rahman

题目:Akkermansia muciniphila extracellular vesicles: Function and theranostic potential in disease

作者:Yu-di Wang, Wen-long Lin, Shang-yuan Wu, Xiao-jing He, Zi-hao Ou, Lei Zheng

04

News and Views

题目:AI empowers the development of hematology: Accelerator or disruptor of scientific discovery?

作者:Er-liang Wang (Interviewer), Chen Chen (Interviewer), Robert Peter Gale (Interviewee)

05

Letter to the Editor

题目:Advancements in Nipah virus vaccine development: Current trends and challenges

作者:Murugesan Rengarajan

0 阅读:2
科创中国

科创中国

中国科协科创中国官方平台